Comparing the efficacy and safety of the ABC-14 regimen (azacitidine, venetoclax, and chidamide) with traditional “3 + 7” intensive induction regimen or AB-14 regimen (venetoclax combined with azacitidine) in newly diagnosed AML: study protocol for a
Authors
Xin Du (ORCID: https://orcid.org/0000-0003-1494-4910)
Hong‐Hong Yan (ORCID: https://orcid.org/0000-0002-6228-2096)
Comparing the efficacy and safety of the ABC-14 regimen (azacitidine, venetoclax, and chidamide) with traditional “3 + 7” intensive induction regimen or AB-14 regimen (venetoclax combined with azacitidine) in newly diagnosed AML: study protocol for a
Xin Du, Hong‐Hong Yan, Jianyu Weng, Peilong Lai et al.
Journal
Trials
Topics
Acute Myeloid Leukemia Research
article
Comparing the efficacy and safety of the ABC-14 regimen (azacitidine, venetoclax, and chidamide) with traditional “3 + 7” intensive induction regimen or AB-14 regimen (venetoclax combined with azacitidine) in newly diagnosed AML: study protocol for a